Skip to main content
EJNMMI Radiopharmacy and Chemistry
Fig. 9 | EJNMMI Radiopharmacy and Chemistry

Fig. 9

From: Current radiotracers to image neurodegenerative diseases

Fig. 9

Overview of available imaging biomarkers detecting characteristics of neurodegenerative diseases ante-mortem/in-vivo and histopathological hallmarks which are/were, so far, only detectable post-mortem. Furthermore, the shift from a phenotypical to a biological definition of neurodegenerative diseases as it currently emerges in research settings is addressed

Back to article page